<table class="drug-table data-table table table-condensed table-bordered"><tbody><tr id="identification"><th class="divider" colspan="2">Identification</th></tr><tr><th>Name</th><td><strong>Oxymetazoline</strong></td></tr><tr><th>Accession Number</th><td><strong>DB00935</strong>&#160; (APRD01158)</td></tr><tr><th>Type</th><td>small molecule</td></tr><tr><th>Groups</th><td>approved</td></tr><tr><th>Description</th><td><p>A direct acting sympathomimetic used as a vasoconstrictor to relieve nasal congestion. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1251)</p></td></tr><tr><th>Structure</th><td><div class="structure"><a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DB00935/image.png"><img alt="Thumb" src="http://structures.wishartlab.com/molecules/DB00935/thumb.png"></a></div><div class="structure-links"><div class="btn-group btn-group-xs"><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00935.mol">MOL</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00935.sdf">SDF</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00935.pdb">PDB</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00935.smiles">SMILES</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00935.inchi">InChI</a><a class="btn btn-info" href="/structures/structures/small_molecule_drugs/DB00935">View Structure</a></div></div></td></tr><tr><th>Synonyms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="synonyms"><thead><th>Synonym</th><th>Language</th><th>Code</th></thead><tbody><tr><td>Oximetazolinum</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Oxymethazoline</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Oxymetozoline</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr></tbody></table></td></tr><tr><th>Salts</th><td class="table-container"><table class="inner">
  <thead>
    <tr>
      <th>Name/CAS</th>
      <th>Structure</th>
      <th>Properties</th>
      <th></th>
    </tr>
  </thead>
  <tbody>
      <tr>
        <td>
          <strong>Oxymetazoline hydrochloride</strong>
          <div class="cas"></div>
        </td>
        <td><a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DBSALT000821/image.png"><img alt="Thumb" src="http://structures.wishartlab.com/molecules/DBSALT000821/thumb.png"></a></td>
        <td>
            <ul>
              <li>InChI Key: BEEDODBODQVSIM-UHFFFAOYSA-N</li>
              <li>Monoisotopic Mass: 296.165541139</li>
              <li>Average Mass: 296.836</li>
            </ul>
        </td>
        <td><a class="btn btn-default btn-xs" href="/salts/DBSALT000821">DBSALT000821</a></td>
      </tr>
  </tbody>
</table></td></tr><tr><th>Brand names</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="brands"><thead><tr><th>Name</th><th>Company</th></tr></thead><tbody><tr><td>Afrin</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Dristan 12-Hour</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Duramist Plus</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Genasal Nasal Spray Up to 12 Hour Relief</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Iliadin</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Mucinex Full Force</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Mucinex Moisture Smart</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Neo-Synephrine 12 Hour Spray</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Nezeril</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Nostrilla 12 Hour Nasal Decongestant</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>OcuClear</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Vicks Sinex 12 Hour Nasal Spray</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Vicks Sinex 12 Hour Ultra Fine Mist for Sinus Relief</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Visine L.R.</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr></tbody></table></td></tr><tr><th>Brand mixtures</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Categories</th><td><ul><li><a href="/mesh/sympathomimetics">Sympathomimetics</a></li>
<li><a href="/mesh/adrenergic-alpha-agonists">Adrenergic alpha-Agonists</a></li>
<li><a href="/mesh/nasal-decongestants">Nasal Decongestants</a></li></ul></td></tr><tr><th>CAS number</th><td>1491-59-4</td></tr><tr><th>Weight</th><td>Average: 260.3746<br>Monoisotopic: 260.1888634</td></tr><tr><th>Chemical Formula</th><td>C<sub>16</sub>H<sub>24</sub>N<sub>2</sub>O</td></tr><tr><th>InChI Key</th><td>WYWIFABBXFUGLM-UHFFFAOYSA-N</td></tr><tr><th>InChI</th><td><div class="wrap">InChI=1S/C16H24N2O/c1-10-8-13(16(3,4)5)15(19)11(2)12(10)9-14-17-6-7-18-14/h8,19H,6-7,9H2,1-5H3,(H,17,18)</div></td></tr><tr><th>IUPAC Name</th><td><div class="wrap">6-tert-butyl-3-(4,5-dihydro-1H-imidazol-2-ylmethyl)-2,4-dimethylphenol</div></td></tr><tr><th>SMILES</th><td><div class="wrap">CC1=CC(=C(O)C(C)=C1CC1=NCCN1)C(C)(C)C</div></td></tr><tr><th>Mass Spec</th><td><a href="/system/mass_specs/DB00935.gif?1265922774">show</a>(10.5 KB)</td></tr><tr id="taxonomy"><th class="divider" colspan="2">Taxonomy</th></tr><tr><th>Kingdom</th><td>Organic Compounds</td></tr><tr><th>Superclass</th><td>Lipids</td></tr><tr><th>Class</th><td>Prenol Lipids</td></tr><tr><th>Subclass</th><td>Monoterpenes</td></tr><tr><th>Direct parent</th><td>Aromatic Monoterpenes</td></tr><tr><th>Alternative parents</th><td>Cumenes; Ortho Cresols; Para Cresols; Toluenes; Enols; Polyamines; Carboxamidines</td></tr><tr><th>Substituents</th><td>p-cresol; o-cresol; toluene; phenol derivative; benzene; amidine; polyamine; enol; carboxylic acid amidine; organonitrogen compound</td></tr><tr><th>Classification description</th><td>This compound belongs to the aromatic monoterpenes. These are monoterpenes containing at least one aromatic ring.</td></tr><tr id="pharmacology"><th class="divider" colspan="2">Pharmacology</th></tr><tr><th>Indication</th><td>For treatment of nasal congestion and redness associated with minor irritations of the eye</td></tr><tr><th>Pharmacodynamics</th><td>Oxymetazoline a adrenergic alpha-agonists, direct acting sympathomimetic used as a vasoconstrictor to relieve nasal congestion The sympathomimetic action of oxymetazoline constricts the smaller arterioles of the nasal passages, producing a prolonged (up to 12 hours), gentle and decongesting effect. Oxymetazoline elicits relief of conjunctival hyperemia by causing vasoconstriction of superficial conjunctival blood vessels. The drug's action has been demonstrated in acute allergic conjunctivitis and in chemical (chloride) conjunctivitis.</td></tr><tr><th>Mechanism of action</th><td>Oxymetazoline is a direct acting sympathomimetic amine, which acts on alpha-adrenergic receptors in the arterioles of the conjunctiva and nasal mucosa. It produces vasoconstriction, resulting in decreased conjunctival congestion in ophthalmic. In nasal it produces constriction, resulting in decreased blood flow and decreased nasal congestion.</td></tr><tr><th>Absorption</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Volume of distribution</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Protein binding</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Metabolism</th><td class="data-table-container"></td></tr><tr><th>Route of elimination</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Half life</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Clearance</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Toxicity</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Affected organisms</th><td><ul><li>Humans and other mammals</li></ul></td></tr><tr><th>Pathways</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Effects</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Adverse Drug Reactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="admet"><th class="divider" colspan="2">ADMET</th></tr><tr><th>Predicted ADMET features</th><td class="data-table-container"><table class="table table-condensed table-striped" id="predicted-admet">
  <thead>
    <tr>
      <th>Property</th>
      <th>Value</th>
      <th>Probability</th>
    </tr>
  </thead>
  <tbody>
      <tr>
        <td>Human Intestinal Absorption</td>
        <td>
              +
        </td>
        <td>0.9761</td>
      </tr>
      <tr>
        <td>Blood Brain Barrier</td>
        <td>
              -
        </td>
        <td>0.5388</td>
      </tr>
      <tr>
        <td>Caco-2 permeable</td>
        <td>
              -
        </td>
        <td>0.567</td>
      </tr>
      <tr>
        <td>P-glycoprotein substrate</td>
        <td>
            Substrate
        </td>
        <td>0.8858</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor I</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.9477</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor II</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.6585</td>
      </tr>
      <tr>
        <td>Renal organic cation transporter</td>
        <td>
            Inhibitor
        </td>
        <td>0.6039</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-substrate</td>
        <td>0.7585</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-substrate</td>
        <td>0.5707</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Non-substrate</td>
        <td>0.5394</td>
      </tr>
      <tr>
        <td>CYP450 1A2 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9045</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9071</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Inhibitor</td>
        <td>0.8931</td>
      </tr>
      <tr>
        <td>CYP450 2C19 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9026</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.854</td>
      </tr>
      <tr>
        <td>CYP450 inhibitory promiscuity</td>
        <td>Low CYP Inhibitory Promiscuity</td>
        <td>0.8682</td>
      </tr>
      <tr>
        <td>Ames test</td>
        <td>
          Non AMES toxic 
        </td>
        <td>
            0.7951
        </td>
      </tr>
      <tr>
        <td>Carcinogenicity</td>
        <td>
          Non-carcinogens 
        </td>
        <td>
            0.8923
        </td>
      </tr>
      <tr>
        <td>Biodegradation</td>
        <td>
          Not ready biodegradable 
        </td>
        <td>
            1.0
        </td>
      </tr>
      <tr>
        <td>Rat acute toxicity</td>
        <td>
          4.4155 
            LD50, mol/kg
        </td>
        <td>
            <span class="wishart wishart-not-available">Not applicable</span>
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor I)</td>
        <td>
          Weak inhibitor 
        </td>
        <td>
            0.8402
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor II)</td>
        <td>
          Non-inhibitor 
        </td>
        <td>
            0.7432
        </td>
      </tr>
  </tbody>
</table>
</td></tr><tr id="pharmacoeconomics"><th class="divider" colspan="2">Pharmacoeconomics</th></tr><tr><th>Manufacturers</th><td><ul><li>Schering plough healthcare products inc</li>
<li>Johnson and johnson group consumer companies</li></ul></td></tr><tr><th>Packagers</th><td><ul><li><a href="http://www.otcdruggist.com/index.html">Altaire Pharmaceuticals</a></li>
<li><a href="http://www.bayerhealthcare.com">Bayer Healthcare</a></li>
<li><a href="http://www.chaindrug.com">Chain Drug</a></li>
<li><a href="http://www.cvs.com">CVS Pharmacy</a></li>
<li><a href="http://www.palmettopharm.com">Palmetto Pharmaceuticals Inc.</a></li>
<li><a href="http://www.perrigo.com">Perrigo Co.</a></li>
<li><a href="http://www.pfizer.com">Pfizer Inc.</a></li>
<li>S&amp;P Healthcare</li>
<li><a href="http://www.spectrumpharm.com">Spectrum Pharmaceuticals</a></li>
<li><a href="http://www.target.com">Target Corp.</a></li>
<li><a href="http://www.walgreens.com">Walgreen Co.</a></li>
<li><a href="http://www.wyeth.com">Wyeth Pharmaceuticals</a></li></ul></td></tr><tr><th>Dosage forms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="dosages"><thead><tr><th>Form</th><th>Route</th><th>Strength</th></tr></thead><tbody><tr><td>Liquid</td><td>Nasal</td><td></td></tr><tr><td>Solution</td><td>Nasal</td><td></td></tr><tr><td>Solution</td><td>Respiratory (inhalation)</td><td></td></tr><tr><td>Solution / drops</td><td>Ophthalmic</td><td></td></tr><tr><td>Spray</td><td>Nasal</td><td></td></tr></tbody></table></td></tr><tr id="spectra"><th class="divider" colspan="2">Spectra</th></tr><tr><th>Spectra</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="interactions"><th class="divider" colspan="2">Interactions</th></tr><tr><th>Drug Interactions</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><thead><tr><th>Drug</th><th style="width: 75%"></th></tr></thead><tbody><tr><td><a href="/drugs/DB00752">Tranylcypromine</a></td><td>The MAO inhibitor, Tranylcypromine, may increase the vasopressor effect of the alpha1-agonist, Oxymetazoline. Concomitant therapy should be avoided. </td></tr></tbody></table></td></tr><tr><th>Food Interactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr></tbody></table>